LOXL 2 Promotes the Epithelial–Mesenchymal Transition and Malignant Progression of Cervical Cancer [Retraction]

Tian J, Sun HX, Li YC, Jiang L, Zhang SL, Hao Q. Onco Targets Ther. 2019;12:8947–8954. https://doi.org/10.2147/OTT.S217794

We, the Editors and Publisher of the journal OncoTargets and Therapy, have retracted the published article.

After publication, concerns have been raised by a third party in 2024 about the integrity of the data in Figure 3 of the article.

Further investigation conducted by the Journal and Publisher identified significant integrity concerns due to unexpected overlaps in Figure 3B of the article with figures in the following article by an unrelated author group:

Wang X-h, Gan C-z, Xie J-y. Inhibition of miR-24 suppresses malignancy of human non-small cell lung cancer cells by targeting WWOX in vitro and in vivo. Thorac Cancer. 2018;9:1583-1593. https://doi.org/10.1111/1759-7714.12824

When approached for an explanation, the authors did not respond to the queries raised by the Journal and Publisher.

As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The corresponding author listed in this publication has been informed.

We have been informed in our decision-making by our editorial policies and the COPE guidelines.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.